Literature DB >> 10966738

Discovery of potent antagonists of the interaction between human double minute 2 and tumor suppressor p53.

C García-Echeverría1, P Chène, M J Blommers, P Furet.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10966738     DOI: 10.1021/jm990966p

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  53 in total

1.  Synthesis of cell-permeable stapled peptide dual inhibitors of the p53-Mdm2/Mdmx interactions via photoinduced cycloaddition.

Authors:  Michael M Madden; Avinash Muppidi; Zhenyu Li; Xiaolong Li; Jiandong Chen; Qing Lin
Journal:  Bioorg Med Chem Lett       Date:  2011-01-07       Impact factor: 2.823

Review 2.  Understanding protein non-folding.

Authors:  Vladimir N Uversky; A Keith Dunker
Journal:  Biochim Biophys Acta       Date:  2010-02-01

3.  Development of small molecules designed to modulate protein-protein interactions.

Authors:  Ye Che; Bernard R Brooks; Garland R Marshall
Journal:  J Comput Aided Mol Des       Date:  2006-04-19       Impact factor: 3.686

Review 4.  Targeting protein-protein interfaces using macrocyclic peptides.

Authors:  Meng Gao; Kui Cheng; Hang Yin
Journal:  Biopolymers       Date:  2015-07       Impact factor: 2.505

5.  Beta-peptides with improved affinity for hDM2 and hDMX.

Authors:  Elizabeth A Harker; Douglas S Daniels; Danielle A Guarracino; Alanna Schepartz
Journal:  Bioorg Med Chem       Date:  2009-01-23       Impact factor: 3.641

6.  Targeting tumor suppressor networks for cancer therapeutics.

Authors:  Xuning Emily Guo; Bryan Ngo; Aram Sandaldjian Modrek; Wen-Hwa Lee
Journal:  Curr Drug Targets       Date:  2014-01       Impact factor: 3.465

7.  Design and Synthesis of Functionalized Trisaccharides as p53-Peptide Mimics.

Authors:  Kaori Sakurai; Daniel Kahne
Journal:  Tetrahedron Lett       Date:  2010-07-21       Impact factor: 2.415

Review 8.  Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunities.

Authors:  Jessica Plati; Octavian Bucur; Roya Khosravi-Far
Journal:  J Cell Biochem       Date:  2008-07-01       Impact factor: 4.429

9.  Doxorubicin and 5-fluorouracil induced accumulation and transcriptional activity of p53 are independent of the phosphorylation at serine 15 in MCF-7 breast cancer cells.

Authors:  Matthew T Balmer; Ryan D Katz; Si Liao; James S Goodwine; Susannah Gal
Journal:  Cancer Biol Ther       Date:  2014-05-06       Impact factor: 4.742

10.  Peptide, Peptidomimetic, and Small-molecule Antagonists of the p53-HDM2 Protein-Protein Interaction.

Authors:  Peter M Fischer
Journal:  Int J Pept Res Ther       Date:  2006-03-15       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.